A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C Mutation
- Status
- COMPLETED
- Phase
- PHASE1
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of OKI-179 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of XNW7201 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
AMG 404 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1